MedTrace Logo

Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation)

NCT03857711 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2020-02-06

No results posted yet for this study

Summary

To compare prophylactic strategies of atrial fibrillation in patients with CAD and without AF.

Conditions

Interventions

PROCEDURE

Conventional CABG

Coronary artery bypass grafting

PROCEDURE

CABG+ PVI

CABG+ prophylactic epicardial bipolar radiofrequency isolation of the pulmonary veins

PROCEDURE

CABG+ PVI+amiodarone

CABG+PVI+amiodarone (CABG+RFA + class III antiarrhythmic drug- amiodarone)

PROCEDURE

CABG+amiodarone

Sponsors & Collaborators

  • Federal Centre of High Medical Technologies of the RF Ministry of Public Health, Kaliningrad, Russia.

    collaborator UNKNOWN

  • National Research Center of Surgery, Russia

    lead OTHER_GOV

Principal Investigators

  • Amiran Sh. Revishvili · A.V. Vishnevsky National Medical Research Center of Surgery. Moscow. Russian Federation.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2016-12-01
Completion
2022-12-01

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03857711 on ClinicalTrials.gov